Breast cancer cells prices stopped by fifty percent in tandem with the discontinuation of hormone substitute treatment, according to a research published online in the Journal of the National Cancer Institute. The research was reported in the Telegraph in the United Kingdom.
The Telegraph said:
” Dr Prithwish De, of the Canadian Cancer Society, and coworkers, discovered that use HRT dropped from 12.7 percent in 2002 to 4.9 per cent in 2004.
During the very same period bust cancer cells prices dropped by 9.6 percent even though the very same variety of ladies were having mammography tests.
In between 2004 and 2006 use HRT continued to be secure at around five percent of females aged 50 to 59 however bust cancer cells prices began to boost once more.
Dr De created: ‘The results support the hypothesised web link between using hormonal agent replacement treatment and invasive bust cancer cells incidence and show that the sharp decrease in bust cancer cells occurrence in 2002 is most likely discussed by the concurrent decrease in making use of hormone substitute therapy among Canadian women.'”.
The research’s writers claimed these numbers support existing proof of the link in between HRT and breast cancer cells.